Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell lines

Wei Zhang, Michael Peyton, Yang Xie, Junichi Soh, John D. Minna, Adi F. Gazdar, Eugene P. Frenkel

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)

Fingerprint Dive into the research topics of 'Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell lines'. Together they form a unique fingerprint.

Medicine & Life Sciences